Loading clinical trials...
Loading clinical trials...
This study will examine the safety of tivanisiran sodium eye drops versus vehicle when dosed once daily for 1 year in subjects with signs and symptoms of dry eye disease (DED).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sylentis, S.A.
NCT07656688 · Dry Eye Disease (DED)
NCT07605572 · Dry Eye Disease (DED), Diabete Mellitus, and more
NCT07463950 · Dry Eye Disease (DED)
NCT07412860 · Dry Eye Syndromes, Dry Eye Disease (DED)
NCT07363824 · Dry Eye Disease, Iron
Sylentis Investigative Site
Chandler, Arizona
Sylentis Investigative Site
Phoenix, Arizona
FYDES Investigative Site
Glendale, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions